Study of the antibody titer by Influenza vaccination in Rheumatoid Arthritis patients treated with MTX and Biological agents
Not Applicable
- Conditions
- Rheumatoid Arthritis
- Registration Number
- JPRN-UMIN000010405
- Lead Sponsor
- agoya Medical Center, National Hospital Organization in JAPA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 170
Inclusion Criteria
Not provided
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effects on influenza antibody titer of MTX and biological agents in Japan Seropositive rate Seroconversion rate Change antibody rate
- Secondary Outcome Measures
Name Time Method Correlation between antibody titer and disease activity flu vaccine safety